OpEdNews |
Did you or your children use the blockbuster asthma drug Singulair?
OpEdNews World sales of Merck's asthma drug Singulair were about $5 billion a year until 2012 when its patent expired and it was the U.S.'s seventh best-selling drug. But in September, data from an FDA committee were presented that acknowledge "safety concerns" … |
View full post on asthma – Google News